These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 40577)

  • 21. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
    Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
    Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The pharmacokinetics of Oral-Turinabol in humans].
    Schumann W
    Pharmazie; 1991 Sep; 46(9):650-4. PubMed ID: 1798729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of toloxatone in man following intravenous and oral administrations.
    Benedetti MS; Rovei V; Dencker SJ; Nagy A; Johansson R
    Arzneimittelforschung; 1982; 32(3):276-80. PubMed ID: 7200786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-performance liquid chromatographic determination of pipotiazine in human plasma and urine.
    le Roux Y; Gaillot J; Bieder A
    J Chromatogr; 1982 Jul; 230(2):401-8. PubMed ID: 6125523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ethmozin pharmacokinetics after a single intravenous administration].
    Piotrovskiĭ VK; Merkulova IN; Romina NN; Metelitsa VI
    Kardiologiia; 1982 May; 22(5):75-80. PubMed ID: 7047858
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuroleptic drug levels and therapeutic response: preliminary observations with red blood cell bound butaperazine.
    Garver DL; Dekirmenjian H; Davis JM; Casper R; Ericksen S
    Am J Psychiatry; 1977 Mar; 134(3):304-7. PubMed ID: 14514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of oral trifluoperazine disposition in man.
    Midha KK; Korchinski ED; Verbeeck RK; Roscoe RM; Hawes EM; Cooper JK; McKay G
    Br J Clin Pharmacol; 1983 Mar; 15(3):380-2. PubMed ID: 6849769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chronic administration of centrally acting compounds on chloramphenicol metabolism in schizophrenic patients.
    Watanabe A
    Pharmacology; 1974; 11(4):253-6. PubMed ID: 4156595
    [No Abstract]   [Full Text] [Related]  

  • 32. Review of clinical trials with pipotiazine, pipotiazine undecylenate and pipotiazine palmitate.
    Brown-Thomsen J
    Acta Psychiatr Scand Suppl; 1973; 241():119-38. PubMed ID: 4151807
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-induced handwriting changes: an empirical review.
    Gross LJ
    Tex Rep Biol Med; 1975; 33(3):370-90. PubMed ID: 7025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF concentrations and clinical effects following intravenous dixyrazine premedication.
    Oikkonen M; Kärkelä J; Seppälä T
    Eur J Clin Pharmacol; 1995; 47(5):445-7. PubMed ID: 7720767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Butaperazine pharmacokinetics. Effect of dosage regimen on steady state blood levels.
    Cooper TB; Simpson GM; Haher EF; Bergner PE
    Arch Gen Psychiatry; 1975 Jul; 32(7):903-5. PubMed ID: 239664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidance on switching away from Piportil Depot® (pipotiazine palmitate) injection.
    Haddad P; Taylor M; Patel MX; Taylor D
    Br J Psychiatry; 2015 Jun; 206(6):521. PubMed ID: 26034183
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions.
    Garver DL; Davis JM; Dekirmenjian H; Jones FD; Casper R; Haraszti J
    Arch Gen Psychiatry; 1976 Jul; 33(7):862-6. PubMed ID: 8025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personality trait dependent performance under psilocybin.
    Fischer R; Kappeler T; Wisecup P; Thatcher K
    Dis Nerv Syst; 1970 Feb; 31(2):92-101. PubMed ID: 5438334
    [No Abstract]   [Full Text] [Related]  

  • 39. Measurement of handwriting area to pressure ratios during psilocybin-induced hallucinations.
    Fischer R; Kappeler T; Wisecup P; Thatcher K
    Agents Actions; 1969 Jul; 1(1):42-52. PubMed ID: 5406119
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of hydroflumethiazide during repeated oral administration to healthy subjects.
    Brørs O; Jacobsen S
    Eur J Clin Pharmacol; 1979 May; 15(4):281-6. PubMed ID: 477713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.